Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The reliance of many cancers on aerobic glycolysis has stimulated substantial efforts to develop inhibitors of enzymes in this pathway, including lactate dehydrogenase (LDH). However, despite significant efforts, there have been no reports to date of an LDH inhibitor (LDHi) with sufficient specificity and in vivo activity to determine whether LDH is a feasible drug target and if LDH inhibition alone will suppress growth of glycolytic tumors. Here we describe an LDHi with potent, on-target in vivo activity that has allowed us to address these questions. Using hyperpolarized magnetic resonance spectroscopic imaging (HP-MRSI) of [13C]pyruvate metabolism, we demonstrate dynamic in vivo LDH inhibition in two glycolytic cancer models, MIA PaCa-2 and HT29, and we correlate LDH inhibition with direct anti-tumor activity. However, HP-MRSI also reveals a metabolic rewiring that occurs within 30 min of LDH inhibition in vivo, wherein pyruvate flux in tumor xenografts is redirected toward mitochondrial metabolism, consistent with perturbation of the NADH/NAD+ redox couple. HP-MRSI also shows that in vivo inhibition of mitochondrial complex 1 inhibition rapidly redirects tumor pyruvate flux toward lactate and, importantly, inhibition of both mitochondrial complex 1 and LDH suppresses metabolic plasticity and drives these cancer cells into metabolic quiescence in vivo while causeing tumor stasis in vivo. These data highlight the importance of pyruvate flux in tumor metabolic plasticity in vivo, even in glycolytic models, and they demonstrate the utility of HP-MRSI in monitoring drug-dependent changes in tumor metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fundamentals of Cancer Metabolism
DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · cited 1×
“Recent advances in metabolomics, medicinal chemistry, and imaging techniques now make it possible to test the hypothesis that glycolysis and oxidative phosphorylation are functionally integrated in vivo and that both are essential to maintaining metabolic plasticity and tumor growth (DeBerardinis and Chandel, 2016; Ji…”
BackgroundMitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742 · cited 1×
“Recent advances in metabolomics, medicinal chemistry, and imaging techniques now make it possible to test the hypothesis that glycolysis and oxidative phosphorylation are functionally integrated in vivo and that both are essential to maintaining metabolic plasticity and tumor growth (DeBerardinis and Chandel, 2016; Ji…”
BackgroundFantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · cited 3×
“Importantly, although the natural product FX11 does display in vivo activity, it also has significant off-target effects and is not specific for LDH (Billiard et al., 2013; Fantin et al., 2006; Granchi et al., 2013; Le et al., 2010; Ward et al., 2012; Xie et al., 2014).”
BackgroundMetformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
Madiraju, A. K., Erion, D. M., Rahimi, Y., Zhang, X.-M., Braddock, D. T., Albright, R. A., Prigaro, B. J., Wood, J. L., Bhanot, S., MacDonald, M. J., et al. (2014) · Nature · doi:10.1038/nature13270 · Cited by 1,284 · cited 1×
“Based on previous reports (Foretz et al., 2010; Madiraju et al., 2014), we administered metformin (50 mg/kg) orally to tumor-bearing mice.”
MethodForetz, M., Hébrard, S., Leclerc, J., Zarrinpashneh, E., Soty, M., Mithieux, G., Sakamoto, K., Andreelli, F., & Viollet, B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40671 · Cited by 1,181 · cited 1×
“Based on previous reports (Foretz et al., 2010; Madiraju et al., 2014), we administered metformin (50 mg/kg) orally to tumor-bearing mice.”
MethodAn inhibitor of oxidative phosphorylation exploits cancer vulnerability
Molina, J. R., Sun, Y., Protopopova, M., Gera, S., Bandi, M., Bristow, C., McAfoos, T., Morlacchi, P., Ackroyd, J., Agip, A.-N. A., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0052-4 · Cited by 928 · cited 3×
“The mitochondrial complex 1 inhibitor IACS-010759 was previously described by Molina et al. (2018) and was synthesized following the published procedure.”
MethodInfluentialMetabolic determinants of cancer cell sensitivity to glucose limitation and biguanides
Birsoy, K., Possemato, R., Lorbeer, F. K., Bayraktar, E. C., Thiru, P., Yucel, B., Wang, T., Chen, W. W., Clish, C. B., & Sabatini, D. M. (2014) · Nature · doi:10.1038/nature13110 · Cited by 710
Xie, H., Hanai, J.-I., Ren, J.-G., Kats, L., Burgess, K., Bhargava, P., Signoretti, S., Billiard, J., Duffy, K. J., Grant, A., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.003 · Cited by 516
Assessing bioenergetic function in response to oxidative stress by metabolic profiling
Dranka, B. P., Benavides, G. A., Diers, A. R., Giordano, S., Zelickson, B. R., Reily, C., Zou, L., Chatham, J. C., Hill, B. G., Zhang, J., et al. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.005 · Cited by 436
Self-citationDaemen, A., Peterson, D., Sahu, N., McCord, R., Du, X., Liu, B., Kowanetz, K., Hong, R., Moffat, J., Gao, M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501605112 · Cited by 398
Cited by
Cancer metabolism: looking forward
Martínez-Reyes, I., & Chandel, N. S. (2021) · Nature Reviews Cancer · doi:10.1038/s41568-021-00378-6 · Cited by 1,824
Targeting cancer metabolism in the era of precision oncology
Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00339-6 · Cited by 1,189
Self-citationMitochondrial Metabolism as a Target for Cancer Therapy
Vasan, K., Werner, M., & Chandel, N. S. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.019 · Cited by 736
Lactate and lactylation in cancer
Chen, J., Huang, Z., Chen, Y., Tian, H., Chai, P., Shen, Y., Yao, Y., Xu, S., Ge, S., & Jia, R. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02082-x · Cited by 477
The multiple roles of LDH in cancer
Claps, G., Faouzi, S., Quidville, V., Chehade, F., Shen, S., Vagner, S., & Robert, C. (2022) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00686-2 · Cited by 351
Metadata
- Authors
- Oshima, N., Ishida, R., Kishimoto, S., Beebe, K., Brender, J. R., Yamamoto, K., Urban, D., Rai, G., Johnson, M. S., Benavides, G., Squadrito, G. L., Crooks, D., Jackson, J., Joshi, A., Mott, B. T., Shrimp, J. H., Moses, M. A., Lee, M.-J., Yuno, A., Lee, T. D., Hu, X., Anderson, T., Kusewitt, D., Hathaway, H. H., Jadhav, A., Picard, D., Trepel, J. B., Mitchell, J. B., Stott, G. M., Moore, W., Simeonov, A., Sklar, L. A., Norenberg, J. P., Linehan, W. M., Maloney, D. J., Dang, C. V., Waterson, A. G., Hall, M., Darley-Usmar, V. M., Krishna, M. C., & Neckers, L. M.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 30
- Issue
- 6
- Pages
- 1798-1810.e4
- ISSN
- 2211-1247 (ISSN-L)
- OpenAlex
- W2979832385
- Cited by
- 125
- References
- 12
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy. https://app.cochat.ai/papers/10.1016/j.celrep.2020.01.039
- The paper
- Oshima, N., Ishida, R., Kishimoto, S., Beebe, K., Brender, J. R., Yamamoto, K., Urban, D., Rai, G., Johnson, M. S., Benavides, G., Squadrito, G. L., Crooks, D., Jackson, J., Joshi, A., Mott, B. T., Shrimp, J. H., Moses, M. A., Lee, M.-J., Yuno, A., . . . Neckers, L. M. (2020). Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy. Cell Reports. https://doi.org/10.1016/j.celrep.2020.01.039
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.